NASDAQ:SRPT   Sarepta Therapeutics, Inc.
Chart is not looking bullish or aggressively bearish, needs to start building higher lows if it wants to fill the gap to $30.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.